Adjuvant treatment of renal cell carcinoma with vascular endothelial growth factor inhibitors is feasible and effective with careful patient selection and standard dosing levels.
European urology. 2017 Sep 07 [Epub ahead of print]
Bernard Escudier, Michael Staehler
Gustave Roussy Cancer Institute, Villejuif Cedex, France. Electronic address: ., Department of Urology, University of Munich, Klinikum Grosshadern, Munich, Germany.